What is NovoCure's shares (diluted)?

NovoCure (NVCR) reported shares (diluted) of 114.1M in Q1 2026.

How has NovoCure's shares (diluted) changed year-over-year?

NovoCure's shares (diluted) increased by 3.5% year-over-year, from 110.3M to 114.1M.

What is the long-term trend for NovoCure's shares (diluted)?

Over 4 years (2021 to 2025), NovoCure's shares (diluted) has grown at a 1.9% compound annual growth rate (CAGR), from 413.7M to 445.2M.

What does shares (diluted) mean?

The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.

NovoCure NVCR Shares (Diluted)

Shares (Diluted) at other companies

Boston ScientificBSX

1.5B+0.1%

MedtronicMDT

1.3B-0.1%

Iovance Biotherapeutics, Inc.IOVA

418.5M+29.6%

Nuvation BioNUVB

377.5M+11.5%

Vir Biotechnology, Inc.VIR

147.4M+7.2%

Syndax PharmaceuticalsSNDX

88.3M+2.4%

Other financials

Income statement

See full

Revenue$174.1M+12.3%

Gross profit$135.1M+16.0%

Operating income-$67.4M-78.1%

Net income-$71.1M-107%

EPS (diluted)-$0.62-100%

Balance sheet

See full

Cash & equivalents$87.5M-31.2%

Total debt$39.5M-2.1%

Total equity$330.7M-8.6%

Total assets$787.9M-36.9%

Cash flow

See full

Operating cash flow-$13.5M+62.1%

CapEx$5.2M-51.4%

Free cash flow-$18.7M+59.7%

Valuation

See full

Market cap$1.7B-36.7%

Profitability

See full

Gross margin75.2%-2.0pp

Operating margin-27.2%+0.4pp

Net margin-25.7%-0.7pp

FCF margin-7.1%-2.0pp

Returns & leverage

See full

Return on equity-50%+5.4pp

Debt / equity0.1×0.0×

Current ratio2.9×+1.4×

Where this comes from

Reported directly by NovoCure in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The official record: NovoCure’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about NovoCure's shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is NovoCure's shares (diluted)?: NovoCure (NVCR) reported shares (diluted) of 114.1M in Q1 2026.
How has NovoCure's shares (diluted) changed year-over-year?: NovoCure's shares (diluted) increased by 3.5% year-over-year, from 110.3M to 114.1M.
What is the long-term trend for NovoCure's shares (diluted)?: Over 4 years (2021 to 2025), NovoCure's shares (diluted) has grown at a 1.9% compound annual growth rate (CAGR), from 413.7M to 445.2M.
What does shares (diluted) mean?: The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.